Eli Lilly Kisunla Donanemab Injection 350mg 20ml Vial

Kisunla (donanemab) is a monoclonal antibody treatment designed for adults with Alzheimer’s disease. This medication actively targets amyloid-beta plaques within the brain to help manage disease progression. Each single-dose vial contains 350 mg of active medication in a 20 mL solution. Administration must be performed by a qualified healthcare professional via intravenous infusion. This therapy provides an essential option for those managing Alzheimer’s related neurological conditions.

Manufacturer: Eli Lilly
Active Ingredient: Donanemab
Medicine Classification: Monoclonal Antibody
Indication: Alzheimer's Disease
Dosage Strength: 350 mg
Volume: 20 mL
Administration: Intravenous (IV) Infusion
Product Type: Central Nervous System